Transcatheter arterial chemoembolization combined with apatinib and camrelizumab for unresectable advanced gastric or gastroesophageal junction cancer: a single-arm, single-center, retrospective study

• Published in: Frontiers in oncology Vol. 13; p. 1143578
• Main Authors: Wu, Kunpeng, Li, Yahua, Li, Zongming, Zhou, Zihe, Ge, Xiaoyong, Li, Yifan, Han, Xinwei, Chen, Peng, Ren, Kewei
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 06.09.2023
• Subjects: comprehensive therapy; gastric or gastroesophageal junction cancer; immunotherapy; Oncology; TACE; targeted therapy

Purpose This study aims to investigate the efficacy and safety of transcatheter arterial chemoembolization (TACE) combined with Apatinib and Camrelizumab for treating unresectable advanced gastric or gastroesophageal junction (G/GEJ) cancer. Material and methods In this study, data of patients with...